Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Shionogi Relinquishes HIV Portfolio; Joins Pfizer, GSK As Shareholders In ViiV

Related Content

Japanese Earnings Roundup: Shionogi Rebounds From U.S. Acquisition Woes With C&O Pharmaceutical For China; Astellas Ponders Mirabegron's Reproductive Warning

Aug 02 2011

Mutation Resistance Could Differentiate Shionogi/ViiV’s Dolutegravir

Sep 28 2012

Related Companies

Shionogi & Co. Ltd.

ViiV Healthcare

GSK plc

Pfizer Inc.

C&O Pharmaceutical Technology (Holdings) Limited

Victory Pharma, Inc.

Merck & Co., Inc.

Gilead Sciences, Inc.

Additional Topics

Japan Asia Pacific Deals BioPharmaceutical

More from Japan

More from Focus On Asia

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window